Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 404

1.

Misoprostol effects on diclofenac-induced cardiorenal changes in salt-sensitive patients with hypertension: the MEDIC Study.

Munger MA, Gardner SF, Ateshkadi A, Rabetoy GM, Barri YM, Stoddard GJ, Cheung AK; MEDIC Study Investigators.

Pharmacotherapy. 2008 Jul;28(7):834-42. doi: 10.1592/phco.28.7.834.

PMID:
18576898
2.
4.

Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.

Mistry GC, Maes AL, Lasseter KC, Davies MJ, Gottesdiener KM, Wagner JA, Herman GA.

J Clin Pharmacol. 2008 May;48(5):592-8. doi: 10.1177/0091270008316885. Epub 2008 Mar 19.

PMID:
18353996
5.

The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.

Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z; Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.

Clin Ther. 2008 Mar;30(3):482-98. doi: 10.1016/j.clinthera.2008.03.006.

PMID:
18405787
6.

Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes.

Farker K, Merkel U, Schweer H, Haerting J, Madani SF, Eggers R, Müller UA, Seyberth HW, Hoffmann A.

Eur J Clin Pharmacol. 2002 May;58(2):85-91. Epub 2002 Mar 28.

PMID:
12012138
7.

Effects of misoprostol on healing and prevention of biopsy-induced gastroduodenal lesions occurring during the administration of diclofenac to volunteers.

Dorta G, Nicolet M, Vouillamoz D, Margalith D, Blum AL, Armstrong D, Saraga E.

Aliment Pharmacol Ther. 1996 Aug;10(4):563-9. Erratum in: Aliment Pharmacol Ther 1996 Oct;10(5):833.

PMID:
8853760
8.

Hemodynamic and renal effects of indomethacin in losartan-treated hypertensive individuals.

Olsen ME, Thomsen T, Hassager C, Ibsen H, Dige-Petersen H.

Am J Hypertens. 1999 Feb;12(2 Pt 1):209-16.

PMID:
10090350
9.

No effect of misoprostol on renal function of rheumatoid patients treated with diclofenac.

Boers M, Dijkmans BA, Breedveld FC, Camps JA, Chang PC, Van Brummelen P, Pauwels EK, Cats A.

Br J Rheumatol. 1991 Feb;30(1):56-9.

PMID:
1899350
10.

Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial.

Ottesen LH, Aagaard NK, Kiszka-Kanowitz M, Rehling M, Henriksen JH, Pedersen EB, Flyvbjerg A, Bendtsen F.

Hepatology. 2001 Sep;34(3):471-7.

PMID:
11526531
12.

An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.

Miranda RD, Mion D Jr, Rocha JC, Kohlmann O Jr, Gomes MA, Saraiva JF, Amodeo C, Filho BL.

Clin Ther. 2008 Sep;30(9):1618-28. doi: 10.1016/j.clinthera.2008.09.008.

PMID:
18840367
13.

The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects.

Mathur VS, Swan SK, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, Epstein M, Luther RR.

Crit Care Med. 1999 Sep;27(9):1832-7.

PMID:
10507606
14.
15.

Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients.

Hansen KW, Klein F, Christensen PD, Sørensen K, Andersen PH, Møller J, Pedersen EB, Christiansen JS, Mogensen CE.

Diabete Metab. 1994 Sep-Oct;20(5):485-93.

PMID:
7859897
16.

Effects of moxonidine on stress-induced peak blood pressure and renal function: a randomized, double-blind, placebo-controlled crossover study.

Fauvel JP, Najem R, Maakel N, Pozet N, Laville M.

J Cardiovasc Pharmacol. 1998 Sep;32(3):495-9.

PMID:
9733365
17.

Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?

Pritchard G, Lyons D, Webster J, Petrie JC, MacDonald TM.

Br J Clin Pharmacol. 1997 Aug;44(2):145-9.

18.

Renal effects of oral prostaglandin supplementation after ibuprofen in diabetic subjects: a double-blind, placebo-controlled, multicenter trial.

Bakris GL, Starke U, Heifets M, Polack D, Smith M, Leurgans S.

J Am Soc Nephrol. 1995 Mar;5(9):1684-8.

20.

A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.

Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.

Clin Ther. 2008 Nov;30(11):2030-9. doi: 10.1016/j.clinthera.2008.11.003.

PMID:
19108791

Supplemental Content

Support Center